Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa F Long

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Plos One|November 24, 2011
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysisElisa F Long
Breast Cancer Research and Treatment|March 9, 2019
Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancerBingnan Zhang, Elisa F Long
Annals of the American Thoracic Society|March 31, 2015
A Conceptual Framework for Improving Critical Care Patient Flow and Bed UseKusum S Mathews, Elisa F Long
Vaccine|April 23, 2011
The cost-effectiveness of a modestly effective HIV vaccine in the United StatesElisa F Long, Douglas K Owens
Journal of General Internal Medicine|April 17, 2013
Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysisElisa F Long, Robert R Stavert
Production and Operations Management|December 25, 2019
The Boarding Patient: Effects of ICU and Hospital Occupancy Surges on Patient FlowElisa F Long, Kusum S Mathews
Science Advances|September 12, 2020
Political storms: Emergent partisan skepticism of hurricane risksElisa F Long, M Keith Chen, Ryne Rohla
Operations Research|May 5, 2009
Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection DynamicsElisa F Long, Naveen K Vaidya, Margaret L Brandeau
Vaccine|July 14, 2009
Potential population health outcomes and expenditures of HIV vaccination strategies in the United StatesElisa F Long, Margaret L Brandeau, Douglas K Owens
Circulation. Heart Failure|February 25, 2014
Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failureElisa F Long, Gary W Swain, Abeel A Mangi
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Plos One|November 24, 2011
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysisElisa F Long
Breast Cancer Research and Treatment|March 9, 2019
Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancerBingnan Zhang, Elisa F Long
Annals of the American Thoracic Society|March 31, 2015
A Conceptual Framework for Improving Critical Care Patient Flow and Bed UseKusum S Mathews, Elisa F Long
Vaccine|April 23, 2011
The cost-effectiveness of a modestly effective HIV vaccine in the United StatesElisa F Long, Douglas K Owens
Journal of General Internal Medicine|April 17, 2013
Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysisElisa F Long, Robert R Stavert
Production and Operations Management|December 25, 2019
The Boarding Patient: Effects of ICU and Hospital Occupancy Surges on Patient FlowElisa F Long, Kusum S Mathews
Science Advances|September 12, 2020
Political storms: Emergent partisan skepticism of hurricane risksElisa F Long, M Keith Chen, Ryne Rohla
Operations Research|May 5, 2009
Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection DynamicsElisa F Long, Naveen K Vaidya, Margaret L Brandeau
Vaccine|July 14, 2009
Potential population health outcomes and expenditures of HIV vaccination strategies in the United StatesElisa F Long, Margaret L Brandeau, Douglas K Owens
Circulation. Heart Failure|February 25, 2014
Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failureElisa F Long, Gary W Swain, Abeel A Mangi
Pageof 3